Related Experiment Video
Updated: Mar 26, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
The ophthalmic presentation of Hermansky-Pudlak syndrome 6
Sarah Hull1,2, Gavin Arno1,2, Graham E Holder1,2
1University College London Institute of Ophthalmology, London, UK.
Insights
Hermansky-Pudlak syndrome (HPS) diagnosis was delayed in patients with mild systemic symptoms. Genetic sequencing identified HPS6 variants, highlighting its role in oculocutaneous albinism and systemic complications.
Area of Science:
- Ophthalmology
- Genetics
- Hematology
Background:
- Hermansky-Pudlak syndrome (HPS) can mimic oculocutaneous albinism, necessitating its consideration due to potential systemic complications.
- HPS6 is a rare subtype of HPS, presenting diagnostic challenges.
Observation:
- Three patients from two families presented with ocular symptoms like nystagmus and reduced vision, initially misdiagnosed.
- Mild systemic symptoms including easy bruising and nosebleeds were noted upon further investigation.
- Visual-evoked potentials (VEPs) showed no aberrant chiasmal misrouting in initial assessments.
Findings:
- Whole exome sequencing (WES) identified a novel homozygous missense variant in HPS6 in one family.
- Sanger sequencing revealed biallelic, truncating mutations in HPS6, including a novel variant, in another patient.
- Abnormal platelet function confirmed the diagnosis of HPS in all affected individuals.
Implications:
- Delayed diagnosis of HPS, even with mild systemic phenotypes, can lead to preventable morbidity.
- Next-generation sequencing techniques are crucial for diagnosing syndromic conditions like HPS.
- Early and accurate diagnosis of HPS6 is essential for managing potential systemic complications.
Background:
Hermansky-Pudlak syndrome (HPS) may present to the ophthalmologist with signs suggestive of oculocutaneous albinism. Consideration of HPS as a differential diagnosis is important due to its potential systemic complications. HPS6 is a rarely reported subtype.
Methods:
Three patients from two families underwent clinical examination, imaging and targeted systemic investigations. Electrophysiology with visual-evoked potentials (VEPs) was performed in both children of family 1. Whole exome sequencing (WES) was performed on the proband of family 1. Bidirectional Sanger sequencing of the single exon and intron-exon boundaries of HPS6 was performed on all affected patients and segregation confirmed in available relatives.
Results:
Two siblings presented in infancy with nystagmus and reduced vision. They were initially diagnosed with isolated foveal hypoplasia with no aberrant chiasmal misrouting on VEPs. WES performed in the proband when 10 years of age identified a novel homozygous missense variant in HPS6 and further questioning elicited a history of nose bleeds and mild bruising. Segregation supported causality of this variant in the affected younger sibling. In the third unrelated patient, an initial diagnosis of ocular albinism was made at 3 months with HPS only diagnosed at 26 years. Biallelic, truncating mutations in HPS6 were identified by candidate Sanger sequencing and included a novel variant. Abnormal platelet function consistent with HPS was confirmed in all patients.
Conclusions:
The diagnosis of HPS in all patients was delayed due to a mild systemic phenotype. Next-generation sequencing can aid diagnosis of syndromic conditions with important consequences for preventing morbidity.
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

